Safety and Efficacy of Encapsulated Allogeneic MPS-1 Therapy
Clinical trial NCT05665036 · WITHDRAWN
Trial details
- NCT number
- NCT05665036
- Sponsor
- Sigilon Therapeutics, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-15
- Primary completion
- 2022-12-13
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.